These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


213 related items for PubMed ID: 14726893

  • 1. Methotrexate and psoriasis in the era of new biologic agents.
    Saporito FC, Menter MA.
    J Am Acad Dermatol; 2004 Feb; 50(2):301-9. PubMed ID: 14726893
    [No Abstract] [Full Text] [Related]

  • 2. Methotrexate and liver toxicity: role of surveillance liver biopsy. Conflict between guidelines for rheumatologists and dermatologists.
    Hassan W.
    Ann Rheum Dis; 1996 May; 55(5):273-5. PubMed ID: 8660097
    [No Abstract] [Full Text] [Related]

  • 3. Immunogenicity of biologic treatments for psoriasis: therapeutic consequences and the potential value of concomitant methotrexate.
    Farhangian ME, Feldman SR.
    Am J Clin Dermatol; 2015 Aug; 16(4):285-294. PubMed ID: 25963062
    [Abstract] [Full Text] [Related]

  • 4. Methotrexate in psoriasis: consensus conference.
    Roenigk HH, Auerbach R, Maibach H, Weinstein G, Lebwohl M.
    J Am Acad Dermatol; 1998 Mar; 38(3):478-85. PubMed ID: 9520032
    [No Abstract] [Full Text] [Related]

  • 5. Methotrexate and other chemotherapeutic agents used to treat psoriasis.
    Jeffes EW, Weinstein GD.
    Dermatol Clin; 1995 Oct; 13(4):875-90. PubMed ID: 8785891
    [Abstract] [Full Text] [Related]

  • 6. Intermittent, short term use of methotrexate for exacerbations of psoriasis.
    Clark AR, Feldman SR.
    Int J Dermatol; 1997 Dec; 36(12):954-5. PubMed ID: 9466209
    [No Abstract] [Full Text] [Related]

  • 7. Fatal, incidental, idiopathic pulmonary fibrosis in a patient receiving long-term low-dose methotrexate for psoriasis.
    Affleck A, Goudie A, Smith R.
    Clin Exp Dermatol; 2019 Jul; 44(5):591-592. PubMed ID: 30919996
    [No Abstract] [Full Text] [Related]

  • 8. Yellow nail pigmentation due to methotrexate.
    Malka N, Reichert S, Trechot P, Barbaud A, Schmutz JL.
    Dermatology; 1998 Jul; 197(3):276. PubMed ID: 9867364
    [No Abstract] [Full Text] [Related]

  • 9. Erythema gyratum repens-like eruption occuring in resolving psoriasis during methotrexate therapy.
    Singal A, Sonthalia S, Pandhi D.
    Int J Dermatol; 2010 Mar; 49(3):306-7. PubMed ID: 20465670
    [No Abstract] [Full Text] [Related]

  • 10. Safety of Systemic Agents for the Treatment of Pediatric Psoriasis.
    Bronckers IMGJ, Seyger MMB, West DP, Lara-Corrales I, Tollefson M, Tom WL, Hogeling M, Belazarian L, Zachariae C, Mahé E, Siegfried E, Philipp S, Szalai Z, Vleugels RA, Holland K, Murphy R, Baselga E, Cordoro K, Lambert J, Alexopoulos A, Mrowietz U, Kievit W, Paller AS, Psoriasis Investigator Group (PsIG) of the Pediatric Dermatology Research Alliance and the European Working Group on Pediatric Psoriasis (EWGPP).
    JAMA Dermatol; 2017 Nov 01; 153(11):1147-1157. PubMed ID: 28903160
    [Abstract] [Full Text] [Related]

  • 11. Use of methotrexate in patients with psoriasis.
    Kuhn A, Ruland V, Patsinakidis N, Luger TA.
    Clin Exp Rheumatol; 2010 Nov 01; 28(5 Suppl 61):S138-44. PubMed ID: 21044448
    [Abstract] [Full Text] [Related]

  • 12. A randomized controlled trial of methotrexate and cyclosporine in the treatment of psoriasis.
    Bigby M.
    Arch Dermatol; 2004 Mar 01; 140(3):347-8. PubMed ID: 15023778
    [No Abstract] [Full Text] [Related]

  • 13. Methotrexate hepatotoxicity: what is the evidence?
    Ahern MJ, Smith MD, Roberts-Thomson PJ.
    Inflamm Res; 1998 Apr 01; 47(4):148-51. PubMed ID: 9628257
    [No Abstract] [Full Text] [Related]

  • 14. Clearance in psoriasis treatment.
    Kumar B, Saraswat A.
    J Am Acad Dermatol; 2001 Jul 01; 45(1):153-4. PubMed ID: 11423858
    [No Abstract] [Full Text] [Related]

  • 15. [Methotrexate therapy in psoriasis].
    Bournerias I.
    Rev Prat; 2004 Jan 15; 54(1):52-5. PubMed ID: 15049601
    [Abstract] [Full Text] [Related]

  • 16. Systemic therapy of psoriasis using methotrexate.
    Smith KC.
    Skin Therapy Lett; 2000 Jan 15; 6(3):1-2; 5. PubMed ID: 11176041
    [Abstract] [Full Text] [Related]

  • 17. Methotrexate in the treatment of psoriasis.
    Bright RD.
    Cutis; 1999 Nov 15; 64(5):332-4. PubMed ID: 10582158
    [Abstract] [Full Text] [Related]

  • 18. Monitoring liver function during methotrexate therapy for psoriasis: are routine biopsies really necessary?
    Thomas JA, Aithal GP.
    Am J Clin Dermatol; 2005 Nov 15; 6(6):357-63. PubMed ID: 16343024
    [Abstract] [Full Text] [Related]

  • 19. [Methotrexate in psoriasis: do we need to give a test dose?].
    Carretero-Hernández G.
    Actas Dermosifiliogr; 2012 Nov 15; 103(1):1-4. PubMed ID: 22093543
    [No Abstract] [Full Text] [Related]

  • 20. The acitretin and methotrexate combination therapy for psoriasis vulgaris achieves higher effectiveness and less liver fibrosis.
    An J, Zhang D, Wu J, Li J, Teng X, Gao X, Li R, Wang X, Xia L, Xia Y.
    Pharmacol Res; 2017 Jul 15; 121():158-168. PubMed ID: 28414177
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.